2011 - 2020 of 6255 Results
Title
Year
- FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression2009OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2666445Citation Count: 47
-
OPENTitle: Using global statistical tests in long‐term Parkinson's disease clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 12Start Page: 1732End Page: 1739Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22645Best OA location URL: http://doi.org/10.1002/mds.22645Citation Count: 40
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 134
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 92
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8